Humoral and Cellular Immunity to SARS-CoV-2 Vaccination in Cancer Patients: Completed Prospective Observational Study Using BNT162b2 mRNA Vaccine (2021)
Attributed to:
Evaluation of the CD4+ T cell tumour microenvironment of low grade B cell lymphoproliferative disorders
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2139/ssrn.3919693
Publication URI: http://dx.doi.org/10.2139/ssrn.3919693
Type: Journal Article/Review
Parent Publication: SSRN Electronic Journal